[HTML][HTML] 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and …
A Fourquet, C Aveline, O Cussenot, G Créhange… - Scientific Reports, 2020 - nature.com
We aimed to evaluate the impact of prostate-specific membrane antigen ligand labelled with
gallium-68 (PSMA-11) PET/CT in restaging patients with castration-resistant nonmetastatic …
gallium-68 (PSMA-11) PET/CT in restaging patients with castration-resistant nonmetastatic …
A comparison of 18F-DCFPyL, 18F-NaF, and 18F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer
A Fourquet, A Rosenberg, E Mena… - Journal of Nuclear …, 2022 - Soc Nuclear Med
18 F-DCFPyL, 18 F-sodium fluoride ( 18 F-NaF), and 18 F-FDG PET/CT were compared in a
prospective cohort of men with metastatic prostate cancer (PCa). Methods: Sixty-seven men (…
prospective cohort of men with metastatic prostate cancer (PCa). Methods: Sixty-seven men (…
Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
…, L Lindenberg, B Turkbey, A Fourquet… - Journal of Nuclear …, 2022 - Soc Nuclear Med
Our objective was to investigate the factors predicting scan positivity and disease location in
patients with biochemical recurrence (BCR) of prostate cancer (PCa) after primary local …
patients with biochemical recurrence (BCR) of prostate cancer (PCa) after primary local …
[HTML][HTML] Restaging the Biochemical Recurrence of Prostate Cancer with [68Ga]Ga-PSMA-11 PET/CT: Diagnostic Performance and Impact on Patient Disease …
A Fourquet, L Lahmi, T Rusu, Y Belkacemi… - Cancers, 2021 - mdpi.com
Simple Summary We aimed to evaluate the diagnostic performance, impact on patient
disease management, and therapy efficacy prediction of [ 68 Ga]Ga-PSMA-11 PET/CT on 294 …
disease management, and therapy efficacy prediction of [ 68 Ga]Ga-PSMA-11 PET/CT on 294 …
Pulmonary Vein Varix Mimicking Prostate Cancer Metastasis on 68Ga–Prostate Specific Membrane Antigen-11 PET/CT
B Sgard, F Montravers, A Fourquet… - Clinical Nuclear …, 2020 - journals.lww.com
The use of PET/CT with prostate-specific membrane antigen radioligands for staging prostate
cancer patients presenting a biochemical recurrence is increasing. As a consequence, the …
cancer patients presenting a biochemical recurrence is increasing. As a consequence, the …
Brain 123I-FP-CIT SPECT of a Holmes tremor due to midbrain pilocytic astrocytoma
N Louarn, D Kharroubi, A Fourquet… - Clinical Nuclear …, 2020 - journals.lww.com
A 24-year-old woman with an unresectable right mesencephalic pilocytic astrocytoma was
treated with stereotaxic radiation therapy. Three months after a radiation therapy–induced …
treated with stereotaxic radiation therapy. Three months after a radiation therapy–induced …
[CITATION][C] Performances diagnostiques de la TEP/TDM au ligand du PSMA marqué au gallium-68 dans la récidive biologique du cancer de la prostate
A Fourquet - 2019
[CITATION][C] Use of 68Ga-PSMA-11 PET/CT in the detection of prostate cancer recurrence of non metastatic castrate-resistant patients: posivity rate and impact on …
M Gauthé, A Fourquet, C Aveline, F Montravers… - 2019 - EANM'19
[BOOK][B] Les Hatt, une dynastie de brasseurs strasbourgeois de 1664 aux années 1980
N Stoskopf - 2018 - hal.science
Trente-six brasseurs de la famille Hatt sur dix générations et plus de trois siècles, de 1664 à
1989, qui dit mieux ? L’histoire brassicole des Hatt commence en 1664 à Strasbourg et …
1989, qui dit mieux ? L’histoire brassicole des Hatt commence en 1664 à Strasbourg et …